HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro

Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs...

Full description

Saved in:
Bibliographic Details
Published inAIDS research and human retroviruses Vol. 28; no. 10; p. 1313
Main Authors Hernández, Juan C, Stevenson, Mario, Latz, Eicke, Urcuqui-Inchima, Silvio
Format Journal Article
LanguageEnglish
Published United States 01.10.2012
Subjects
Online AccessGet more information
ISSN1931-8405
DOI10.1089/aid.2011.0297

Cover

Loading…
Abstract Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs play a key role in regulating the expression of proinflammatory cytokines and viral pathogenesis. In the present study, the effect of HIV-1 stimulation of monocyte-derived macrophage (MDM) and peripheral blood mononuclear cell (PBMC) subpopulations from healthy donors on the expression and functions of TLR2 and TLR4 was examined. In addition, and to complete the in vitro study, the expression pattern of TLR2 and TLR4 in 49 HIV-1-infected patients, classified according to viral load and the use of HAART, was determined and compared with 25 healthy subjects. An increase of TLR expression and production of proinflammatory cytokines were observed in MDMs and PBMCs infected with HIV-1 in vitro and in response to TLR stimulation, compared to the mock. In addition, an association between TLR expression and up-regulation of CD80 in plasmacytoid dendritic cells (pDCs) was observed. The ex vivo analysis indicated increased expression of TLR2 and TLR4 in myeloid dendritic cells (mDCs), but only of TLR2 in monocytes obtained from HIV-1-infected patients, compared to healthy subjects. Remarkably, the expression was higher in cells from patients who do not use HAART. In monocytes, there was a positive correlation between both TLRs and viral load, but not CD4(+) T cell numbers. Together, our in vitro and ex vivo results suggest that TLR expression and function can be up-regulated in response to HIV-1 infection and could affect the inflammatory response. We propose that modulation of TLRs represents a mechanism to promote HIV-1 replication or AIDS progression in HIV-1-infected patients.
AbstractList Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs play a key role in regulating the expression of proinflammatory cytokines and viral pathogenesis. In the present study, the effect of HIV-1 stimulation of monocyte-derived macrophage (MDM) and peripheral blood mononuclear cell (PBMC) subpopulations from healthy donors on the expression and functions of TLR2 and TLR4 was examined. In addition, and to complete the in vitro study, the expression pattern of TLR2 and TLR4 in 49 HIV-1-infected patients, classified according to viral load and the use of HAART, was determined and compared with 25 healthy subjects. An increase of TLR expression and production of proinflammatory cytokines were observed in MDMs and PBMCs infected with HIV-1 in vitro and in response to TLR stimulation, compared to the mock. In addition, an association between TLR expression and up-regulation of CD80 in plasmacytoid dendritic cells (pDCs) was observed. The ex vivo analysis indicated increased expression of TLR2 and TLR4 in myeloid dendritic cells (mDCs), but only of TLR2 in monocytes obtained from HIV-1-infected patients, compared to healthy subjects. Remarkably, the expression was higher in cells from patients who do not use HAART. In monocytes, there was a positive correlation between both TLRs and viral load, but not CD4(+) T cell numbers. Together, our in vitro and ex vivo results suggest that TLR expression and function can be up-regulated in response to HIV-1 infection and could affect the inflammatory response. We propose that modulation of TLRs represents a mechanism to promote HIV-1 replication or AIDS progression in HIV-1-infected patients.
Author Stevenson, Mario
Hernández, Juan C
Urcuqui-Inchima, Silvio
Latz, Eicke
Author_xml – sequence: 1
  givenname: Juan C
  surname: Hernández
  fullname: Hernández, Juan C
  organization: Grupo Inmunovirología, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia
– sequence: 2
  givenname: Mario
  surname: Stevenson
  fullname: Stevenson, Mario
– sequence: 3
  givenname: Eicke
  surname: Latz
  fullname: Latz, Eicke
– sequence: 4
  givenname: Silvio
  surname: Urcuqui-Inchima
  fullname: Urcuqui-Inchima, Silvio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22280204$$D View this record in MEDLINE/PubMed
BookMark eNo1T99LwzAYDKK4H_roq-QfaP3yJemSRxnqBgVBpk_CSNsvUtnS0rTD_ffSTZ_uOO6Ouxm7DE0gxu4EpAKMfXB1lSIIkQLaxQWbCitFYhToCZvF-A0AFlFfswkiGkBQU_a5Wn_w_tgSF7wOnsq-bgIf2qSjr2Hneop8k78hd6EaieL003YU4-gaNT-Ec6QO_FAfmpN44n3X3LAr73aRbv9wzt6fnzbLVZK_vqyXj3lSKg19QsU4a-GkV4CZt0ZLZyslM0LnTFEoTUZhKTBT3suFJJ85TU5gaQtJUuCc3Z9726HYU7Vtu3rvuuP2_yb-AqiwUy0
CitedBy_id crossref_primary_10_1016_j_crviro_2022_100021
crossref_primary_10_1016_j_isci_2024_110131
crossref_primary_10_1002_jcp_28103
crossref_primary_10_1097_MD_0000000000023663
crossref_primary_10_1016_S2222_1808_16_61089_7
crossref_primary_10_3389_fimmu_2019_00874
crossref_primary_10_3390_cells12121565
crossref_primary_10_3390_app14177526
crossref_primary_10_2139_ssrn_2988029
crossref_primary_10_3389_fimmu_2018_02039
crossref_primary_10_3389_fimmu_2022_879600
crossref_primary_10_1016_j_jneuroim_2014_03_002
crossref_primary_10_1371_journal_pone_0119844
crossref_primary_10_1016_j_jneuroim_2018_01_015
crossref_primary_10_3390_ijms24119624
crossref_primary_10_1002_jev2_12027
crossref_primary_10_1159_000371765
crossref_primary_10_3390_biology13030146
crossref_primary_10_1007_s12026_015_8748_8
crossref_primary_10_3389_fimmu_2021_738743
crossref_primary_10_1189_jlb_4VMR0415_160R
crossref_primary_10_1189_jlb_3HI0516_242R
crossref_primary_10_1038_gene_2014_54
crossref_primary_10_1016_j_gene_2020_144366
crossref_primary_10_1371_journal_pone_0185162
crossref_primary_10_1007_s13365_024_01239_2
crossref_primary_10_1590_S0036_46652012000300008
crossref_primary_10_1186_s12879_023_08495_3
crossref_primary_10_3389_fimmu_2025_1541152
crossref_primary_10_1007_s12026_015_8691_8
crossref_primary_10_1089_vim_2018_0093
crossref_primary_10_1371_journal_pntd_0002060
crossref_primary_10_3389_fmicb_2020_01452
crossref_primary_10_3390_v15112206
crossref_primary_10_1128_JVI_02048_16
crossref_primary_10_3389_fimmu_2020_589010
crossref_primary_10_1155_2024_9399524
crossref_primary_10_1097_COH_0000000000000096
crossref_primary_10_1007_s13365_018_0629_1
crossref_primary_10_1099_jgv_0_000345
crossref_primary_10_4236_wja_2012_23029
crossref_primary_10_3390_v13102054
crossref_primary_10_3390_microorganisms8111787
crossref_primary_10_1007_s12026_016_8876_9
crossref_primary_10_3390_pathogens12070880
crossref_primary_10_3390_diseases3040282
crossref_primary_10_1097_QAD_0000000000000381
crossref_primary_10_3389_fcell_2021_724970
crossref_primary_10_3390_v15010052
crossref_primary_10_3390_vaccines11121861
crossref_primary_10_1016_j_semnephrol_2017_07_004
crossref_primary_10_1038_icb_2015_26
crossref_primary_10_1016_j_vaccine_2014_09_010
crossref_primary_10_3390_ijms24021465
crossref_primary_10_1172_jci_insight_145928
crossref_primary_10_1089_aid_2013_0115
crossref_primary_10_3389_fimmu_2019_01777
crossref_primary_10_1128_JVI_01767_13
crossref_primary_10_1371_journal_pone_0072789
crossref_primary_10_1371_journal_ppat_1004311
crossref_primary_10_3390_genes12010036
crossref_primary_10_1177_1753425917738331
crossref_primary_10_1016_S1473_3099_14_70917_X
crossref_primary_10_3389_fimmu_2018_03092
crossref_primary_10_1189_jlb_4A1215_534R
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1089/aid.2011.0297
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1931-8405
ExternalDocumentID 22280204
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI083713
– fundername: NHLBI NIH HHS
  grantid: R01 HL112661
– fundername: NHLBI NIH HHS
  grantid: R01 HL093262
GroupedDBID ---
-~X
.55
.GJ
0R~
1CY
23M
34G
39C
4.4
53G
5GY
5RE
6J9
ABBKN
ABJNI
ACGFO
ACGFS
ACPRK
ADBBV
AENEX
AFFNX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BNQNF
CAG
CGR
COF
CS3
CUY
CVF
EBS
ECM
EIF
EJD
F5P
IAO
IH2
IHR
IM4
INH
INR
ITC
L7B
MV1
N8Y
NPM
NQHIM
O9-
P2P
RIG
RML
RMSOB
UAP
UE5
X7M
ZGI
ID FETCH-LOGICAL-c450t-eb92257a3f4026f9853a9d436e2aa8bb45e842c1264ff373ef6a5ea12c9b3e312
IngestDate Thu Apr 03 06:54:42 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c450t-eb92257a3f4026f9853a9d436e2aa8bb45e842c1264ff373ef6a5ea12c9b3e312
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3482876
PMID 22280204
ParticipantIDs pubmed_primary_22280204
PublicationCentury 2000
PublicationDate 2012-10-01
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle AIDS research and human retroviruses
PublicationTitleAlternate AIDS Res Hum Retroviruses
PublicationYear 2012
References 18769358 - J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35
9841825 - J Infect Dis. 1999 Jan;179(1):74-82
15373913 - Clin Exp Immunol. 2004 Oct;138(1):116-21
18382686 - PLoS One. 2008;3(4):e1915
19098484 - AIDS. 2009 Jan 14;23(2):147-60
15728447 - J Immunol. 2005 Mar 1;174(5):2457-65
16034093 - J Immunol. 2005 Aug 1;175(3):1551-7
19690337 - Blood. 2009 Oct 29;114(18):3854-63
20521908 - Clin Infect Dis. 2010 Jul 15;51(2):242-7
17532476 - J Reprod Immunol. 2008 Jan;77(1):91-9
18184082 - AIDS Res Hum Retroviruses. 2007 Nov;23(11):1387-95
11160291 - J Immunol. 2001 Feb 15;166(4):2342-7
20719993 - J Gen Virol. 2010 Nov;91(Pt 11):2804-13
17048704 - Curr Top Microbiol Immunol. 2006;311:17-58
15718836 - AIDS. 2005 Feb 18;19(3):261-71
1280600 - FEBS Lett. 1992 Apr 13;301(1):23-8
15622449 - J Clin Immunol. 2004 Nov;24(6):647-52
17301562 - AIDS. 2007 Feb 19;21(4):441-6
11861616 - Annu Rev Immunol. 2002;20:709-60
19821521 - Hepatology. 2010 Jan;51(1):35-42
11561001 - J Exp Med. 2001 Sep 17;194(6):863-9
19265483 - J Infect Dis. 2009 Apr 15;199(8):1195-204
20113369 - Immunology. 2010 Jun;130(2):202-16
21425908 - Immunol Invest. 2011;40(5):498-522
15635478 - J Mol Med (Berl). 2005 Mar;83(3):180-92
20862220 - PLoS One. 2010;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831
19769961 - Exp Mol Pathol. 2010 Feb;88(1):26-31
17997401 - Exp Mol Pathol. 2008 Feb;84(1):31-6
12776992 - Curr Mol Med. 2003 Jun;3(4):373-85
20610663 - Clin Vaccine Immunol. 2010 Sep;17(9):1417-27
20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40
18031241 - Biochem Soc Trans. 2007 Dec;35(Pt 6):1437-44
19513613 - J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):313-7
19945134 - Virology. 2010 Feb 5;397(1):34-42
17507480 - J Virol. 2007 Aug;81(15):8180-91
15241424 - Nature. 2004 Jul 8;430(6996):257-63
15622324 - AIDS. 2004 Dec 3;18(18):2437-9
17720662 - HIV Clin Trials. 2007 Jul-Aug;8(4):221-6
19109163 - J Immunol. 2009 Jan 1;182(1):319-28
12853962 - Nature. 2003 Jul 10;424(6945):213-9
18356597 - AIDS. 2008 Mar 30;22(6):685-94
19447460 - Virology. 2009 Jun 20;389(1-2):20-5
19855253 - AIDS. 2009 Nov 27;23(18):2387-95
11777946 - J Immunol. 2002 Jan 15;168(2):554-61
17084417 - Life Sci. 2007 Jan 2;80(4):307-13
20145198 - J Leukoc Biol. 2010 Jun;87(6):1133-43
17713639 - Biomedica. 2007 Jun;27(2):280-93
16224540 - J Clin Invest. 2005 Nov;115(11):3265-75
15307037 - Clin Infect Dis. 2004 Jul 15;39(2):264-9
19426550 - BMC Cell Biol. 2009;10:37
18334250 - Cell Immunol. 2007 Nov-Dec;250(1-2):75-84
19439987 - Intervirology. 2009;52(2):107-14
15539158 - Immunity. 2004 Nov;21(5):733-41
17360657 - Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401
20147631 - J Immunol. 2010 Mar 15;184(6):2814-24
15034054 - J Immunol. 2004 Apr 1;172(7):4391-401
20479248 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178-83
18556339 - Diabetes Care. 2008 Sep;31(9):1827-31
17907802 - PLoS Pathog. 2007 Sep 7;3(9):1281-90
21406030 - AIDS Res Hum Retroviruses. 2011 Oct;27(10):1099-109
19419540 - Retrovirology. 2009;6:42
19239434 - APMIS. 2009 Feb;117(2):124-32
19461969 - PLoS One. 2009;4(5):e5644
12734363 - J Immunol. 2003 May 15;170(10):5159-64
References_xml – reference: 18356597 - AIDS. 2008 Mar 30;22(6):685-94
– reference: 19855253 - AIDS. 2009 Nov 27;23(18):2387-95
– reference: 19439987 - Intervirology. 2009;52(2):107-14
– reference: 20719993 - J Gen Virol. 2010 Nov;91(Pt 11):2804-13
– reference: 19447460 - Virology. 2009 Jun 20;389(1-2):20-5
– reference: 18334250 - Cell Immunol. 2007 Nov-Dec;250(1-2):75-84
– reference: 15307037 - Clin Infect Dis. 2004 Jul 15;39(2):264-9
– reference: 20521908 - Clin Infect Dis. 2010 Jul 15;51(2):242-7
– reference: 20145198 - J Leukoc Biol. 2010 Jun;87(6):1133-43
– reference: 15622324 - AIDS. 2004 Dec 3;18(18):2437-9
– reference: 12776992 - Curr Mol Med. 2003 Jun;3(4):373-85
– reference: 19109163 - J Immunol. 2009 Jan 1;182(1):319-28
– reference: 15034054 - J Immunol. 2004 Apr 1;172(7):4391-401
– reference: 11561001 - J Exp Med. 2001 Sep 17;194(6):863-9
– reference: 20113369 - Immunology. 2010 Jun;130(2):202-16
– reference: 18184082 - AIDS Res Hum Retroviruses. 2007 Nov;23(11):1387-95
– reference: 9841825 - J Infect Dis. 1999 Jan;179(1):74-82
– reference: 19098484 - AIDS. 2009 Jan 14;23(2):147-60
– reference: 19426550 - BMC Cell Biol. 2009;10:37
– reference: 15539158 - Immunity. 2004 Nov;21(5):733-41
– reference: 17907802 - PLoS Pathog. 2007 Sep 7;3(9):1281-90
– reference: 20862220 - PLoS One. 2010;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831
– reference: 15635478 - J Mol Med (Berl). 2005 Mar;83(3):180-92
– reference: 21425908 - Immunol Invest. 2011;40(5):498-522
– reference: 12853962 - Nature. 2003 Jul 10;424(6945):213-9
– reference: 15728447 - J Immunol. 2005 Mar 1;174(5):2457-65
– reference: 19821521 - Hepatology. 2010 Jan;51(1):35-42
– reference: 19239434 - APMIS. 2009 Feb;117(2):124-32
– reference: 21406030 - AIDS Res Hum Retroviruses. 2011 Oct;27(10):1099-109
– reference: 18769358 - J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35
– reference: 17532476 - J Reprod Immunol. 2008 Jan;77(1):91-9
– reference: 15718836 - AIDS. 2005 Feb 18;19(3):261-71
– reference: 18031241 - Biochem Soc Trans. 2007 Dec;35(Pt 6):1437-44
– reference: 17301562 - AIDS. 2007 Feb 19;21(4):441-6
– reference: 19513613 - J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):313-7
– reference: 19945134 - Virology. 2010 Feb 5;397(1):34-42
– reference: 19461969 - PLoS One. 2009;4(5):e5644
– reference: 17713639 - Biomedica. 2007 Jun;27(2):280-93
– reference: 20610663 - Clin Vaccine Immunol. 2010 Sep;17(9):1417-27
– reference: 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7
– reference: 17048704 - Curr Top Microbiol Immunol. 2006;311:17-58
– reference: 15622449 - J Clin Immunol. 2004 Nov;24(6):647-52
– reference: 17997401 - Exp Mol Pathol. 2008 Feb;84(1):31-6
– reference: 18556339 - Diabetes Care. 2008 Sep;31(9):1827-31
– reference: 16224540 - J Clin Invest. 2005 Nov;115(11):3265-75
– reference: 15241424 - Nature. 2004 Jul 8;430(6996):257-63
– reference: 19419540 - Retrovirology. 2009;6:42
– reference: 1280600 - FEBS Lett. 1992 Apr 13;301(1):23-8
– reference: 20147631 - J Immunol. 2010 Mar 15;184(6):2814-24
– reference: 18382686 - PLoS One. 2008;3(4):e1915
– reference: 17084417 - Life Sci. 2007 Jan 2;80(4):307-13
– reference: 17507480 - J Virol. 2007 Aug;81(15):8180-91
– reference: 11861616 - Annu Rev Immunol. 2002;20:709-60
– reference: 19690337 - Blood. 2009 Oct 29;114(18):3854-63
– reference: 20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40
– reference: 19769961 - Exp Mol Pathol. 2010 Feb;88(1):26-31
– reference: 17360657 - Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401
– reference: 19265483 - J Infect Dis. 2009 Apr 15;199(8):1195-204
– reference: 12734363 - J Immunol. 2003 May 15;170(10):5159-64
– reference: 11777946 - J Immunol. 2002 Jan 15;168(2):554-61
– reference: 15373913 - Clin Exp Immunol. 2004 Oct;138(1):116-21
– reference: 11160291 - J Immunol. 2001 Feb 15;166(4):2342-7
– reference: 20479248 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178-83
– reference: 17720662 - HIV Clin Trials. 2007 Jul-Aug;8(4):221-6
SSID ssj0009225
Score 2.266149
Snippet Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer...
SourceID pubmed
SourceType Index Database
StartPage 1313
SubjectTerms Acquired Immunodeficiency Syndrome - genetics
Acquired Immunodeficiency Syndrome - immunology
Adolescent
Adult
CD4 Lymphocyte Count
Dendritic Cells - immunology
Female
Flow Cytometry
Gene Expression Regulation, Viral
HIV-1 - metabolism
Humans
Immunity, Innate
Macrophages - immunology
Male
Middle Aged
RNA, Viral - metabolism
Toll-Like Receptor 2 - genetics
Toll-Like Receptor 2 - immunology
Toll-Like Receptor 4 - genetics
Toll-Like Receptor 4 - immunology
Up-Regulation
Viral Load
Young Adult
Title HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro
URI https://www.ncbi.nlm.nih.gov/pubmed/22280204
Volume 28
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELa6ICEuiPcb-cCtMtSPtM5xBYvKinJgW2kPSCs7tUUkNi3ZpAd-Cz-WGdtJwwLicYksu47SzJfJzOSbGUKe58bmLvDCbGGYyteGWactk9oDmrW30mIccvF-Ol-p49PsdDT6NmAttY19UXz9ZV7J_0gV5kCumCX7D5LtTwoTMAb5whEkDMe_kvEcfLcQQ-U9qaoat1tWxwbz7mK8fPdBhO8DMFBYzj_SXiMDGd9pHddxV-42qRITjJt6M7RaD9--PhmnskAxEy629qtdgxGJur3YMxHnrq7C13feRaePW_jpPhgb2qilPK8FeOqbnhNkQm_Z8VEJmqWbXNVF-6UtGeixT-V5sHRPys-7tCuFK7joiW_wtokqNpecgVuZDXWw0EOsTQYalcuYq_qTqp9orJRqynWqwyoiz3cg9u15kDvGuDAF-M-rlypvd0sH5AB8EGyqipGgrqAzKMJUsxWu5OUP14EVptPeS95KsFqWN8mN5G7Qw4idW2Tkqtvk2iIRKu6QjwAhihCinPYQokMIUYQQBZnjQNE9hMJcByHYTBFCYTKMARl3yerN0fLVnKWGG6xQ2aRhzuK_mhnpFbjmPgdTzuRrJadOGKOtVZnTShQcjGjv5Uw6PzWZM1wUucVgurhHrlSbyj0glGtdgDcKxucanAZvjLATaWci8y5TzpqH5H68L2fbWFXlrLtjj3678phc3yPqCbnq4TF2T8EmbOyzIJzvZdpgTw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIV+type+1+infection+up-regulates+TLR2+and+TLR4+expression+and+function+in+vivo+and+in+vitro&rft.jtitle=AIDS+research+and+human+retroviruses&rft.au=Hern%C3%A1ndez%2C+Juan+C&rft.au=Stevenson%2C+Mario&rft.au=Latz%2C+Eicke&rft.au=Urcuqui-Inchima%2C+Silvio&rft.date=2012-10-01&rft.eissn=1931-8405&rft.volume=28&rft.issue=10&rft.spage=1313&rft_id=info:doi/10.1089%2Faid.2011.0297&rft_id=info%3Apmid%2F22280204&rft_id=info%3Apmid%2F22280204&rft.externalDocID=22280204